Skip to content
Disclosery

EXANE DERIVATIVES: URA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on URA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 9,969 URA shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 9,969 shares
    Change vs previous 13F -180 shares

    0.11% of the 13F portfolio, value $184,984.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 10,149 shares
    Change vs previous 13F +10,132 shares

    0.07% of the 13F portfolio, value $265,478.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 17 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $388.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 17 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $404.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 17 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $341.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 17 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $320.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 17 shares
    Change vs previous 13F -11,092 shares

    <0.01% of the 13F portfolio, value $261.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 11,109 shares
    Change vs previous 13F not available

    0.04% of the 13F portfolio, value $123,638.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).